Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

28 Mar 2023 Evaluate

Zydus Lifesciences has informed that it enclosed copy of two press releases, both dated March 28, 2023, ‘Zydus receives Final Approval from the USFDA for Levothyroxine Sodium for Injection’ and ‘Zydus receives Final Approval from the USFDA for Doxepin Hydrochloride Capsules’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..